Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation

American Journal of Transplantation

Volumn 8, Issue 8, 2008, Pages 1719-1728

  Roland, M ^a   Gatault, P ^a   Al Najjar, A ^a   Doute, C ^a   Barbet, C ^a   Chatelet, V ^a   Laouad, I ^b   Marliere J F ^a   Nivet, H ^a   Buchler M ^a   Lebranchu, Y ^a   Halimi, J M ^a  

^a CHU BRETONNEAU   (France)

^b NONE

Author keywords

Diabetes mellitus; Hypertension; Proteinuria; Pulse pressure; Renal transplantation

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BASILIXIMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALBUMINURIA; ARTERIAL PRESSURE; ARTICLE; CAUCASIAN; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEW ONSET DIABETES MELLITUS AFTER TRANSPLANTATION; PRIORITY JOURNAL; PROTEINURIA; PULSE PRESSURE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; DIABETES MELLITUS; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 48349116898     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02308.x     Document Type: Article

References (43)

1. Montori VM, Velosa JA, Basu A, Gabriel SE, Erwin PJ, Kudva YC. Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 2002 25 : 583 592.
2. Roland M, Gatault P, Doute C et al. Tacrolimus, sirolimus and triglycerides as independent risk factors for new-onset diabetes mellitus after kidney transplantation. Transplant Int 2008 21 : 523 530.
3. Kamar N, Mariat C, Delahousse M et al. Diabetes mellitus after kidney transplantation: A French multicentre observational study. Nephrol Dial Transplant 2007 22 : 1986 1993.
4. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after tansplantation: 2003 international consensus guidelines. Transplantation 2003 75 : SS3 SS24.
5. Staatz JN, Thomson AH, Jardine AG. Predictors of new onset diabetes after kidney transplantation. Clin Transplant 2007 19 : 136 143.
6. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 3 : 178 185.
7. Hoitsma AJ, Hilbrands LB. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Clin Transplant 2006 20 : 659 664.
8. Halimi JM, Forhan A, Balkau B et al. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women? J Cardiovasc Risk 2001 8 : 139 146.
9. Brantsma A, Bakker S, Hillege H, Zeeuw D, De Jong P, Gansevoort R for the PREVEND Study group. Urinary albumin Excretion and its relation with C-Reactive Protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005 28 : 2525 2530.
10. Wang Z, Hoy WE. Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. Int J Epidemiol 2006 35 : 1331 1335.
11. Halimi JM, Bonnet F, Lange C, Balkau B, Tichet J, Marre M for the D.E. S.I.R Study group. Urinary albumin excretion s a risk factor for diabetes mellitus in men abstract 0322, EASD congress Available from : http://www.easd-journal.net/pp3_web.pdf. Accessed June 10, 2008.
12. Gress TW, Javie Nieto F, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factor for type 2 diabetes mellitus. N Engl J Med 2000 342 : 905 912.
13. Kasiske BL, Anjum S, Shah R et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004 43 : 1071 1081.
14. Fernandez-Fresnedo G, Plaza JJ, Sanchez-Plumed J, Sanz-Guajardo A, Palormar-Fontanet R, Arias M. Proteinuria: A new marker of long-term transplant graft and patient survival in kidney transplantation. Nephrol Dial Transplant 2004 19 : 47 51.
15. Halimi JM, Laouad I, Büchler M et al. Early low-grade proteinuria: Causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005 5 : 2281 2288.
16. Halimi JM, Büchler M, Al-Najjar A et al. Respective predictive role of urinary albumin excretion and non albumin proteinuria on graft loss and death in renal transplant recipients. Am J Transplant 2007 7 : 2775 2781.
17. Cockcroft DM, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004 27 : S5 S10.
19. Kuypers DR, Claes K, Bammens B, Evenepoel P, Vanrenterghem Y. Early clinical assessment of glucose metabolism in renal allograft recipients: Diagnosis and prediction of post-transplant diabetes mellitus. Nephrol Dial Transplant 2008 23 : 2033 2042.
20. D'Cunha PT, Parasuraman R, Venkat KK. Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation. Am J Transplant 2005 5 : 351 355.
21. Myslak M, Amer H, Morales P et al. Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant 2006 6 : 1660 1665.
22. Tichet J, Vol S, Hallab M, Caces E, Marre M. Epidemiology of microalbuminuria in a french population. J Diabetes Complications 1994 8 : 174 175.
23. Cirillo M, Senigallieri L, Laurenzi M et al. Microalbuminuria in non diabetic-adults: Relation of blood pressure, body mass index, plasma cholesterol and smoking. Arch Intern Med 1998 28 : 1933 1939.
24. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva, Switzerland : World Health Organization, 1999.
25. Wang TJ, Evans JC, Meigs JB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 200 111 : 1370 1376.
26. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003 108 : 2154 2169.
27. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001 103 : 1869 1874.
28. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia 1989 32 : 219 226.
29. Pedersen LM, Sorensen PG. Mediators of inflammation correlate with microalbuminuria in patients with non-Hodgkin's lymphoma. Br J Haematol 2003 121 : 275 279.
30. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007 2 : 581 590.
31. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1992 327 : 707 713.
32. Olsson R, Carlsson PO. The pancreatic islet endothelial cell: Emerging roles in islet function and disease. Int J Biochem Cell Biol 2006 38 : 492 497.
33. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004 291 : 1978 1986.
34. Safar ME. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 2001 10 : 257 261.
35. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. Diabetes Care 2001 24 : 2121 2126.
36. Marin M, Renoult E, Bondor CI, Kessler M. Factors influencing the onset of diabetes mellitus after kidney transplantation: A single French center experience. Transplant Proc 2005 37 : 1851 1856.
37. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001 59 : 732 737.
38. Johnston O, Rose CL, Webster AC, Gill JS. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008 (online: doi :).
39. Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007 357 : 2562 2575.
40. Atkins MB, Hidalgo M, Stadler WM et al. Randomized phase study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. J Clin Oncol 2004 22 : 909 918.
41. Di Paolo S, Teutonico A, Leogrande D, Capobianco C, Schena PF. Chronic inhibition of mammalian target of rapamycin signalling down regulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes. J Am Soc Nephrol 2006 17 : 2236 2244.
42. Zhang N, Su D, Qu S et al. Sirolimus associated with reduced islet engraftment and impaired β-cell function. Diabetes 2006 55 : 2429 2436.
43. Roodnat JI, Mulder PGH, Rischen-Vos J et al. Proteinuria after renal transplantation affects not only graft survival but also patients survival. Transplantation 2001 72 : 438 444.